
Xtant Medical Holdings (XTNT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Xtant Medical Holdings (XTNT) last issued guidance on August 11, 2026 for fiscal year 2026. The company guided revenue in the range of $99M - $103M for the period.
Compared to prior guidance, Xtant Medical Holdings lowered its revenue forecast from a prior range of $101M - $105M.
Xtant Medical Holdings has issued 15 guidance updates between May 4, 2023 and August 11, 2026. During this period, the company raised its outlook 7 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.02 | $-0.02 | $-0.01 | $-0.02 |
| Actual | $-0.03 | $-0.02 | $0.00 | $0.01 |
| Surprise | -50.0% | 0.00% | +100.0% | +150.0% |
| Revenue | ||||
| Estimate | $24.9M | $19.8M | $30.8M | $32.7M |
| Actual | $23.0M | $20.9M | $32.4M | $33.3M |
| Surprise | -7.41% | +5.55% | +5.23% | +1.85% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.02 | $-0.01 |
| Revenue | ||
| Consensus | $25.5M | $30.1M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.03 | $-0.02 | -50.0 % |
| Q1 | May 13, 2026 | $-0.02 | $-0.02 | 0.00 % |
| Q4 | Mar 31, 2026 | $0 | $-0.01 | 100.0 % |
| Q3 | Nov 10, 2025 | $0.01 | $-0.02 | 150.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $23.03M | $24.88M | -7.41 % |
| Q1 | May 13, 2026 | $20.88M | $19.79M | 5.55 % |
| Q4 | Mar 31, 2026 | $32.36M | $30.75M | 5.23 % |
| Q3 | Nov 10, 2025 | $33.30M | $32.70M | 1.85 % |